{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T04:13:53Z","timestamp":1793160833464,"version":"4.5.0"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"Supplement_1","license":[{"start":{"date-parts":[[2019,1,31]],"date-time":"2019-01-31T00:00:00Z","timestamp":1548892800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003130","name":"Fonds voor Wetenschappelijk Onderzoek","doi-asserted-by":"crossref","award":["G043515N"],"award-info":[{"award-number":["G043515N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Ghent University Bijzonder Onderzoeksfonds","award":["BOFGOA2017000502"],"award-info":[{"award-number":["BOFGOA2017000502"]}]},{"DOI":"10.13039\/100014588","name":"Sanofi Pasteur","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100014588","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,4,8]]},"DOI":"10.1093\/infdis\/jiz003","type":"journal-article","created":{"date-parts":[[2019,1,13]],"date-time":"2019-01-13T20:06:35Z","timestamp":1547409995000},"page":"S68-S74","source":"Crossref","is-referenced-by-count":66,"title":["The Role of Matrix Protein 2 Ectodomain in the Development of Universal Influenza Vaccines"],"prefix":"10.1093","volume":"219","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3861-6965","authenticated-orcid":false,"given":"Xavier","family":"Saelens","sequence":"first","affiliation":[{"name":"VIB-UGent Center for Medical Biotechnology, Ghent"},{"name":"Department of Biomedical Molecular Biology, Ghent University, Belgium"},{"name":"Department of Biochemistry and Microbiology, Ghent University, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,4,8]]},"reference":[{"key":"key\n\t\t\t\t2019040805023312600_CIT0001","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/0042-6822(81)90319-6","article-title":"Conservation of the influenza virus membrane protein (M1) amino acid sequence and an open reading frame of RNA segment 7 encoding a second protein (M2) in H1N1 and H3N2 strains","volume":"112","author":"Lamb","year":"1981","journal-title":"Virology"},{"key":"key\n\t\t\t\t2019040805023312600_CIT0002","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/0092-8674(92)90452-I","article-title":"Influenza virus M2 protein has ion channel activity","volume":"69","author":"Pinto","year":"1992","journal-title":"Cell"},{"key":"key\n\t\t\t\t2019040805023312600_CIT0003","doi-asserted-by":"crossref","first-page":"13029","DOI":"10.1128\/JVI.01430-14","article-title":"Stepwise priming by acidic pH and a high K+ concentration is required for efficient uncoating of influenza A virus cores after penetration","volume":"88","author":"Stauffer","year":"2014","journal-title":"J Virol"},{"key":"key\n\t\t\t\t2019040805023312600_CIT0004","doi-asserted-by":"crossref","first-page":"10059","DOI":"10.1128\/JVI.01184-08","article-title":"The influenza virus M2 protein cytoplasmic tail interacts with the M1 protein and influences virus assembly at the site of virus budding","volume":"82","author":"Chen","year":"2008","journal-title":"J Virol"},{"key":"key\n\t\t\t\t2019040805023312600_CIT0005","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.cell.2010.08.029","article-title":"Influenza virus M2 protein mediates ESCRT-independent membrane scission","volume":"142","author":"Rossman","year":"2010","journal-title":"Cell"},{"key":"key\n\t\t\t\t2019040805023312600_CIT0006","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/ni.1861","article-title":"Influenza virus activates inflammasomes via its intracellular M2 ion channel","volume":"11","author":"Ichinohe","year":"2010","journal-title":"Nat Immunol"},{"key":"key\n\t\t\t\t2019040805023312600_CIT0007","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.chom.2014.01.006","article-title":"A LC3-interacting motif in the influenza A virus M2 protein is required to subvert autophagy and maintain virion stability","volume":"15","author":"Beale","year":"2014","journal-title":"Cell Host Microbe"},{"key":"key\n\t\t\t\t2019040805023312600_CIT0008","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1038\/nsmb.1707","article-title":"Solution structure and functional analysis of the influenza B proton channel","volume":"16","author":"Wang","year":"2009","journal-title":"Nat Struct Mol Biol"},{"key":"key\n\t\t\t\t2019040805023312600_CIT0009","doi-asserted-by":"crossref","first-page":"19101","DOI":"10.1016\/S0021-9258(17)46740-8","article-title":"Role of NH2-terminal positively charged residues in establishing membrane protein topology","volume":"268","author":"Parks","year":"1993","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t2019040805023312600_CIT0010","doi-asserted-by":"crossref","first-page":"e1002998","DOI":"10.1371\/journal.ppat.1002998","article-title":"Identification of a novel splice variant form of the influenza A virus M2 ion channel with an antigenically distinct ectodomain","volume":"8","author":"Wise","year":"2012","journal-title":"PloS Pathog"},{"key":"key\n\t\t\t\t2019040805023312600_CIT0011","doi-asserted-by":"crossref","first-page":"11869","DOI":"10.1128\/JVI.01634-08","article-title":"Mutational analysis of cis-acting RNA signals in segment 7 of influenza A virus","volume":"82","author":"Hutchinson","year":"2008","journal-title":"J Virol"},{"key":"key\n\t\t\t\t2019040805023312600_CIT0012","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1006\/viro.2000.0727","article-title":"Combined results from solution studies on intact influenza virus M1 protein and from a new crystal form of its N-terminal domain show that M1 is an elongated monomer","volume":"279","author":"Arzt","year":"2001","journal-title":"Virology"},{"key":"key\n\t\t\t\t2019040805023312600_CIT0013","doi-asserted-by":"crossref","first-page":"8550","DOI":"10.1073\/pnas.1701747114","article-title":"Crystal structure of an orthomyxovirus matrix protein reveals mechanisms for self-polymerization and membrane association","volume":"114","author":"Zhang","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t2019040805023312600_CIT0014","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1002\/pro.2368","article-title":"Conformational analysis of the full-length M2 protein of the influenza A virus using solid-state NMR","volume":"22","author":"Liao","year":"2013","journal-title":"Protein Sci"},{"key":"key\n\t\t\t\t2019040805023312600_CIT0015","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1128\/JVI.02105-15","article-title":"Crystal structure of the conserved amino terminus of the extracellular domain of matrix protein 2 of influenza A virus gripped by an antibody","volume":"90","author":"Cho","year":"2016","journal-title":"J Virol"},{"key":"key\n\t\t\t\t2019040805023312600_CIT0016","doi-asserted-by":"crossref","first-page":"3700","DOI":"10.1128\/JVI.02576-14","article-title":"Structure of the extracellular domain of matrix protein 2 of influenza A virus in complex with a protective monoclonal antibody","volume":"89","author":"Cho","year":"2015","journal-title":"J Virol"},{"key":"key\n\t\t\t\t2019040805023312600_CIT0017","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1128\/JVI.64.3.1375-1377.1990","article-title":"Passively transferred monoclonal antibody to the M2 protein inhibits influenza A virus replication in mice","volume":"64","author":"Treanor","year":"1990","journal-title":"J Virol"},{"key":"key\n\t\t\t\t2019040805023312600_CIT0018","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/0264-410X(95)92777-Y","article-title":"Protection of mice against influenza A virus challenge by vaccination with baculovirus-expressed M2 protein","volume":"13","author":"Slepushkin","year":"1995","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t2019040805023312600_CIT0019","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/13484","article-title":"A universal influenza A vaccine based on the extracellular domain of the M2 protein","volume":"5","author":"Neirynck","year":"1999","journal-title":"Nat Med"},{"key":"key\n\t\t\t\t2019040805023312600_CIT0020","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1080\/14760584.2017.1240041","article-title":"M2-based influenza vaccines: recent advances and clinical potential","volume":"16","author":"Kolpe","year":"2017","journal-title":"Expert Rev Vaccines"},{"key":"key\n\t\t\t\t2019040805023312600_CIT0021","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/eji.200636959","article-title":"Efficient induction of mucosal and systemic immune responses by virus-like particles administered intranasally: implications for vaccine design","volume":"38","author":"Bessa","year":"2008","journal-title":"Eur J Immunol"},{"key":"key\n\t\t\t\t2019040805023312600_CIT0022","doi-asserted-by":"crossref","first-page":"e59081","DOI":"10.1371\/journal.pone.0059081","article-title":"M2e-displaying virus-like particles with associated RNA promote T helper 1 type adaptive immunity against influenza A","volume":"8","author":"Iba\u00f1ez","year":"2013","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t2019040805023312600_CIT0023","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/mt.2012.246","article-title":"Virus-like particles containing multiple M2 extracellular domains confer improved cross-protection against various subtypes of influenza virus","volume":"21","author":"Kim","year":"2013","journal-title":"Mol Ther"},{"key":"key\n\t\t\t\t2019040805023312600_CIT0024","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1128\/JVI.01141-13","article-title":"A novel subnucleocapsid nanoplatform for mucosal vaccination against influenza virus that targets the ectodomain of matrix protein 2","volume":"88","author":"Herv\u00e9","year":"2014","journal-title":"J Virol"},{"key":"key\n\t\t\t\t2019040805023312600_CIT0025","doi-asserted-by":"crossref","first-page":"426","DOI":"10.3201\/eid1303.061125","article-title":"Matrix protein 2 vaccination and protection against influenza viruses, including subtype H5N1","volume":"13","author":"Tompkins","year":"2007","journal-title":"Emerg Infect Dis"},{"key":"key\n\t\t\t\t2019040805023312600_CIT0026","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1093\/infdis\/jit811","article-title":"Serum antibody response to matrix protein 2 following natural infection with 2009 pandemic influenza A(H1N1) virus in humans","volume":"209","author":"Zhong","year":"2014","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t2019040805023312600_CIT0027","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1128\/JVI.62.8.2762-2772.1988","article-title":"Influenza A virus M2 protein: monoclonal antibody restriction of virus growth and detection of M2 in virions","volume":"62","author":"Zebedee","year":"1988","journal-title":"J Virol"},{"key":"key\n\t\t\t\t2019040805023312600_CIT0028","doi-asserted-by":"crossref","first-page":"e02500","DOI":"10.1128\/JVI.02500-16","article-title":"Hierarchical and redundant roles of activating Fc\u03b3Rs in protection against influenza disease by M2e-specific IgG1 and IgG2a antibodies","volume":"91","author":"Van den Hoecke","year":"2017","journal-title":"J Virol"},{"key":"key\n\t\t\t\t2019040805023312600_CIT0029","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.4049\/jimmunol.0902147","article-title":"Universal vaccine based on ectodomain of matrix protein 2 of influenza A: Fc receptors and alveolar macrophages mediate protection","volume":"186","author":"El Bakkouri","year":"2011","journal-title":"J Immunol"},{"key":"key\n\t\t\t\t2019040805023312600_CIT0030","doi-asserted-by":"crossref","first-page":"e14538","DOI":"10.1371\/journal.pone.0014538","article-title":"Influenza virus-like particles containing M2 induce broadly cross protective immunity","volume":"6","author":"Song","year":"2011","journal-title":"PloS One"},{"key":"key\n\t\t\t\t2019040805023312600_CIT0031","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/s41467-017-00928-3","article-title":"Alveolar macrophages are critical for broadly-reactive antibody-mediated protection against influenza A virus in mice","volume":"8","author":"He","year":"2017","journal-title":"Nat Commun"},{"key":"key\n\t\t\t\t2019040805023312600_CIT0032","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1242\/jcs.115.4.849","article-title":"Fc-receptor-mediated phagocytosis is regulated by mechanical properties of the target","volume":"115","author":"Beningo","year":"2002","journal-title":"J Cell Sci"},{"key":"key\n\t\t\t\t2019040805023312600_CIT0033","doi-asserted-by":"crossref","first-page":"4037","DOI":"10.1172\/JCI60659","article-title":"Cross-presenting CD103+ dendritic cells are protected from influenza virus infection","volume":"122","author":"Helft","year":"2012","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t2019040805023312600_CIT0034","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.immuni.2007.07.013","article-title":"Alveolar macrophages are the primary interferon-alpha producer in pulmonary infection with RNA viruses","volume":"27","author":"Kumagai","year":"2007","journal-title":"Immunity"},{"key":"key\n\t\t\t\t2019040805023312600_CIT0035","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1165\/rcmb.2008-0423OC","article-title":"MCP-1 antibody treatment enhances damage and impedes repair of the alveolar epithelium in influenza pneumonitis","volume":"42","author":"Narasaraju","year":"2010","journal-title":"Am J Respir Cell Mol Biol"},{"key":"key\n\t\t\t\t2019040805023312600_CIT0036","doi-asserted-by":"crossref","first-page":"24402","DOI":"10.1038\/srep24402","article-title":"Long-lasting cross-protection against influenza A by neuraminidase and M2e-based immunization strategies","volume":"6","author":"Schotsaert","year":"2016","journal-title":"Sci Rep"},{"key":"key\n\t\t\t\t2019040805023312600_CIT0037","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/mi.2012.69","article-title":"Natural and long-lasting cellular immune responses against influenza in the M2e-immune host","volume":"6","author":"Schotsaert","year":"2013","journal-title":"Mucosal Immunol"},{"key":"key\n\t\t\t\t2019040805023312600_CIT0038","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1086\/498980","article-title":"Prior H1N1 influenza infection and susceptibility of Cleveland Family Study participants during the H2N2 pandemic of 1957: an experiment of nature","volume":"193","author":"Epstein","year":"2006","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t2019040805023312600_CIT0039","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/mi.2017.14","article-title":"M2e-tetramer-specific memory CD4 T cells are broadly protective against influenza infection","volume":"11","author":"Eliasson","year":"2018","journal-title":"Mucosal Immunol"},{"key":"key\n\t\t\t\t2019040805023312600_CIT0040","doi-asserted-by":"crossref","first-page":"5750","DOI":"10.1038\/ncomms6750","article-title":"Ferrets exclusively synthesize Neu5Ac and express naturally humanized influenza A virus receptors","volume":"5","author":"Ng","year":"2014","journal-title":"Nat Commun"},{"key":"key\n\t\t\t\t2019040805023312600_CIT0041","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1016\/j.vaccine.2004.02.021","article-title":"Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys","volume":"22","author":"Fan","year":"2004","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t2019040805023312600_CIT0042","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.ymthe.2017.01.010","article-title":"Safe recombinant outer membrane vesicles that display M2e elicit heterologous influenza protection","volume":"25","author":"Watkins","year":"2017","journal-title":"Mol Ther"},{"key":"key\n\t\t\t\t2019040805023312600_CIT0043","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1099\/0022-1317-83-8-1851","article-title":"Vaccination of pigs with a DNA construct expressing an influenza virus M2-nucleoprotein fusion protein exacerbates disease after challenge with influenza A virus","volume":"83","author":"Heinen","year":"2002","journal-title":"J Gen Virol"},{"key":"key\n\t\t\t\t2019040805023312600_CIT0044","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1159\/000319440","article-title":"Vaccination with different M2e epitope densities confers partial protection against H5N1 influenza A virus challenge in chickens","volume":"54","author":"Zhang","year":"2011","journal-title":"Intervirology"},{"key":"key\n\t\t\t\t2019040805023312600_CIT0045","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.3382\/ps.2009-00251","article-title":"Vaccination of chickens with recombinant Salmonella expressing M2e and CD154 epitopes increases protection and decreases viral shedding after low pathogenic avian influenza challenge","volume":"88","author":"Layton","year":"2009","journal-title":"Poult Sci"},{"key":"key\n\t\t\t\t2019040805023312600_CIT0046","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1093\/infdis\/jiu539","article-title":"Efficacy and safety of treatment with an anti-m2e monoclonal antibody in experimental human influenza","volume":"211","author":"Ramos","year":"2015","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t2019040805023312600_CIT0047","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1016\/j.vaccine.2015.04.073","article-title":"Development of a candidate influenza vaccine based on virus-like particles displaying influenza M2e peptide into the immunodominant region of hepatitis B core antigen: broad protective efficacy of particles carrying four copies of M2e","volume":"33","author":"Tsybalova","year":"2015","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t2019040805023312600_CIT0048","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1067\/mai.2001.116576","article-title":"Preclinical efficacy and safety of mepolizumab (SB-240563), a humanized monoclonal antibody to IL-5, in cynomolgus monkeys","volume":"108","author":"Hart","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"key\n\t\t\t\t2019040805023312600_CIT0049","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1093\/infdis\/jiy177","article-title":"A respiratory syncytial virus vaccine based on the small hydrophobic protein ectodomain presented with a novel lipid-based formulation is highly immunogenic and safe in adults: a first-in-humans study","volume":"218","author":"Langley","year":"2018","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t2019040805023312600_CIT0050","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/14760584.2016.1213632","article-title":"Adjuvant system AS01: helping to overcome the challenges of modern vaccines","volume":"16","author":"Didierlaurent","year":"2017","journal-title":"Expert Rev Vaccines"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/219\/Supplement_1\/S68\/28263970\/jiz003.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,10]],"date-time":"2022-09-10T05:08:37Z","timestamp":1662786517000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/219\/Supplement_1\/S68\/5304896"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,8]]},"references-count":50,"journal-issue":{"issue":"Supplement_1","published-online":{"date-parts":[[2019,4,8]]},"published-print":{"date-parts":[[2019,4,8]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiz003","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,4,15]]},"published":{"date-parts":[[2019,4,8]]}}}